Nathan Seppa

Biomedical Writer (retired September 2015)

All Stories by Nathan Seppa

  1. Health & Medicine

    Bad synergy

    Hookworm and other parasite infections work in concert to heighten risk of anemia in children. The problem may be especially bad for school-aged children, whose learning ability is often compromised by anemia.

  2. Health & Medicine

    Gut feeling

    A bacterial compound can reverse intestinal disease in a mouse, providing the first example of a microbial product “networking” with the mammalian immune system to quell inflammation.

  3. Health & Medicine

    Stunning reversal

    A man’s irregular heartbeat returns to normal after he is shocked with a Taser, the first report of such an effect.

  4. Health & Medicine

    Tracking obesity

    New data suggest that childhood obesity in the United States may have leveled off between 1999 and 2006.

  5. Health & Medicine

    Donor dilemma

    Blood donors age 16 or 17 are more apt to faint than older donors.

  6. Health & Medicine

    Itchy and scratchy

    People with a close relative who has had shingles face a heightened risk of getting the skin disease, and should probably be first in line to get the vaccine.

  7. Health & Medicine

    Glucose galore

    Pregnant women with elevated blood sugar are more likely to have oversized babies, posing a risk to mother and newborn.

  8. Health & Medicine

    Stub it out

    Quitting cigarettes shows health benefits even decades after the last puff.

  9. Health & Medicine

    Potential for protection

    A study of U.S. veterans suggests that the anti-inflammatory drug ibuprofen could have a protective effect against Alzheimer’s disease. But researchers say more work is needed.

  10. Health & Medicine

    Treat ’em

    High blood pressure often goes untreated in people 80 and over, but a new study suggests that treatment extends survival.

  11. Health & Medicine

    Pockets of poor health

    Life expectancy decreases in some locations

  12. Health & Medicine

    New approach might strike at the core of Alzheimer’s disease

    By finding a way to stick an enzyme-inhibiting molecule to the membrane of a cell, scientists may have devised the framework for an Alzheimer’s drug.